April 23, 2012
Daiichi Sankyo announced on April 19 that Terapia Ranbaxy of Romania, an affiliated company of its consolidated subsidiary Ranbaxy Laboratories, will launch its antihypertension Sevikar, a fixed dose combination of olmesartan medoxomil and amlodipine besylate, within this month. This is...read more